Vinva Investment Management Ltd

Position in ABT — Abbott Laboratories

CIK 1968109 SYDNEY, C3

Position in ABT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,457,012

-$15,567,841 QoQ

Shares Held

38,098

-79.4% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#861

of 2,951 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Vinva Investment Management Ltd holds $152,478,853 across 8 Medical Devices names. ABT ranks #6 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PODD	Insulet Corp	430,460	$65,537,535
2	MDT	Medtronic plc	487,011	$38,098,870
3	SYK	Stryker Corp	76,411	$24,057,239
4	BSX	Boston Scientific Corp	292,684	$12,491,753
5	DXCM	Dexcom Inc	74,634	$5,026,599
6	ABT	Abbott Laboratories This page	38,098	$3,457,012
7	STE	STERIS plc	14,412	$3,034,734
8	ENOV	Enovis CORP	37,445	$775,111

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,457,012	38,098	-79.4%	Shares	Sole	2026-08-14
2026-03-31	$19,024,853	185,301	+26.3%	Shares	Sole	2026-05-14
2025-12-31	$18,386,432	146,751	+91.4%	Shares	Sole	2026-02-17
2025-09-30	$10,269,581	76,673	+16.3%	Shares	Sole	2025-11-13
2025-06-30	$8,964,827	65,913	+1.1%	Shares	Sole	2025-08-13
2025-03-31	$8,644,137	65,165	-27.8%	Shares	Sole	2025-05-14
2024-12-31	$10,208,403	90,252	+11.9%	Shares	Sole	2025-02-11
2024-09-30	$9,195,932	80,659	+5.4%	Shares	Sole	2024-11-14
2024-06-30	$7,953,479	76,542	+15.6%	Shares	Sole	2024-08-13
2024-03-31	$7,527,474	66,228	+9.6%	Shares	Sole	2024-05-13
2023-12-31	$6,653,621	60,449	+17.5%	Shares	Sole	2024-02-13
2023-09-30	$4,981,189	51,432	-0.9%	Shares	Sole	2023-11-13
2023-06-30	$5,655,957	51,880	-12.4%	Shares	Sole	2023-08-14
2023-03-31	$5,998,439	59,238	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.